Elloramycin
Elloramycin has weak activity against Gram-positive bacteria, streptomycete and L-1210 leukemic cells, but has no effect on mouse leukemic P388 cells in vivo, and also has a strong inhibition of Streptomyces (including the production of bacteria themselves) activity[1].
Product Specifications
CAS Number
[97218-42-3]
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
CO[C@@]12[C@@](C(C(C(C1=O)=C(C3=C4C)O)=CC3=CC(O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)=C4C(OC)=O)=O)([C@@H](C(OC)=CC2=O)O)O
Molecular Formula
C32H36O15
Molecular Weight
660.62
References & Citations
[1]Angelina Ramos, et al. Biosynthesis of elloramycin in Streptomyces olivaceus requires glycosylation by enzymes encoded outside the aglycon cluster. Microbiology (Reading) . 2008 Mar;154 (Pt 3) :781-788.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6363563-01 0.1 mL
WFIKKN2, CT (WFIKKN2, GASP1, WFIKKNRP, WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 2, Growth and differentiation factor-associated serum protein 1, WAP, follistatin, immunoglobulin, kunitz and NTR domain-containing-related protein
Ask
View Details MBS6363563-02 5x 0.1 mL
WFIKKN2, CT (WFIKKN2, GASP1, WFIKKNRP, WAP, kazal, immunoglobulin, kunitz and NTR domain-containing protein 2, Growth and differentiation factor-associated serum protein 1, WAP, follistatin, immunoglobulin, kunitz and NTR domain-containing-related protein
Ask
View Details 
